Locations
Mason, OH, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series C+
founded in
2013
Genetesis is a medical technology company focused on redefining the diagnosis of myocardial ischemia through its innovative Cardio Flux system. This non-invasive solution leverages magnetocardiography to detect functionally significant ischemia quickly and accurately, aiming to improve patient outcomes and streamline hospital workflows. With FDA 510(k) clearance and Health Canada approval, Cardio Flux is positioned to enhance cardiac imaging and triage processes in emergency departments. The company emphasizes a user-centric approach, integrating 40 years of proven science into modern healthcare practices, and is committed to evolving the standard of care for ischemic heart disease.
Something looks off?On-site & Remote